这个机构已经筛选了另一个瑞士公司——罗氏正在开发的药物，这份不同的协议中同样包括放开专利限制。
The institute has already screened the drugs in development by Roche, another Swiss firm, under a different deal that also involved waiving patent restrictions.
2009年瑞士罗氏制药公司收购了“基因技术公司”及其忙碌的生产线。
Roche, another Swiss drug giant, bought Genentech and its busy cancer pipeline in 2009.
瑞士股市方面，罗氏制药公司股价上涨1.4%，该公司公布了一项削减成本的计划，将减少4800个工作岗位，占总岗位数的6%。
Roche rose 1.4% on the SIX Swiss Exchange after announcing cost-cutting plans that will result in the loss of around 4,800 jobs, or 6% of its workforce.
应用推荐